WPW
NVO

Winthrop Partners - WNY’s Novo Nordisk NVO Stock Holding History

Winthrop Partners - WNY’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$28K Buy
+1,084
New +$27.4K 0.02% 210

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Winthrop Partners - WNY's NVO Position: Q3 2019 in Review

Winthrop Partners - WNY opened a new position in Novo Nordisk (NVO) in Q3 2019: 1,084 shares worth $28K. The stake represents 0.02% of the portfolio and ranks #210 among its holdings.

564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • Winthrop Partners - WNY held 1,084 shares of Novo Nordisk worth $28K as of Q3 2019.
  • Novo Nordisk was a new Winthrop Partners - WNY position in Q3 2019.
  • Novo Nordisk made up 0.02% of Winthrop Partners - WNY's portfolio in Q3 2019, its #210 holding.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.